TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--Mar. 26, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin...

There’s Blood In The Streets…

Normally I love my Saturday mornings. This is when I write the weekly newsletter and it gives me a chance to review the prior...

TFF Pharmaceuticals Announces Phase 1 Clinical Trial Progress for Voriconazole Inhalation Powder to Treat...

Tailwinds' Take: Voriconazole is a generic liquid or tablet that is ingested for diseases like IPA, which start in the lungs. Having a direct...

It’s Definitely a Beer Market

Sometimes a typo can hit the sweet spot, right? When I got the text that we're entering a beer market...well, let's just say that...

TFF Pharmaceuticals Announces Engagement of J.S. Cole & Associates as Strategic Advisor for Partnering...

Tailwinds' Take: very interesting that they have engaged two firms for partnership efforts, first in China, now Japan. We continue to believe that this...

TFF Pharmaceuticals: Particle Engineering to Take Drug Development to the Next Level

TFF Pharmaceuticals has much more promise than meets the eye. Upon inspection, their thin film freezing technology enables an improved drug delivery platform that...

TFF Pharmaceuticals Announces Engagement of Torreya Partners, LLC as Strategic Advisor for Partnering Efforts...

AUSTIN, Texas--(BUSINESS WIRE)-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film...

TFF Pharmaceuticals Reports Continued Progress Across Programs in Corporate Update

AUSTIN, Texas--(BUSINESS WIRE)--Jan. 28, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...

Ascend Capital Founder Malcolm Fairbairn Appointed to TFF Pharmaceuticals Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)--Jan. 28, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.